Pharmacokinetic based adjustment of lidocaine antiarrhythmic schedule
暂无分享,去创建一个
M. Ionescu | M. Jinga | V. Voicu | C. Mircioiu | D. Ionescu | G. Lupescu | X. Burcea
[1] R W Koster,et al. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. , 1985, The New England journal of medicine.
[2] D. Greenblatt,et al. Lidocaine disposition in obesity. , 1984, The American journal of cardiology.
[3] P. R. Reid,et al. Lidocaine kinetics predicted by indocyanine green clearance. , 1978, The New England journal of medicine.
[4] Y. Latour,et al. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. , 1977, Annals of internal medicine.
[5] R. Burney,et al. Anti-arrhythmic effects of lidocaine metabolites. , 1974, American heart journal.
[6] W. Steinbrunn,et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. , 1973, Annals of internal medicine.
[7] A. J. Dunning,et al. Intramuscularly and orally administered lidocaine in the treatment of ventricular arrhythmias in acute myocardial infarction. , 1972, The American journal of cardiology.
[8] D. Scott,et al. Oral Lignocaine , 1970, Lancet.